Pharvaris N.V.
PHVS · XNASCIK 1830487fmd_10NS4H5XM7TTZRSQSDDGYYBK58Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2025, 13 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Research and development | 4 | 6 | 20 | 36 | 57 | 66 | 99 | 124 |
| Operating income | (4) | (8) | (26) | (43) | (76) | (100) | (132) | (174) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | – | – | – |
| Income before taxes | (4) | (8) | (26) | (43) | (76) | (100) | (132) | (174) |
| Income tax expense | 0 | 0 | (0) | 0 | 1 | 1 | 2 | 2 |
| Net income from continuing operations | (4) | (8) | (26) | (43) | (76) | (101) | (134) | (176) |
| Net income | (4) | (8) | (26) | (43) | (76) | (101) | (134) | (176) |